Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

CURE's Top Stories: May 2020

June 2nd 2020, 1:10am

Article

Each month, we take a look back at the most popular CURE® stories. Here are the top five stories for May 2020.

Finding Meaning While Waiting in the Infusion Chair

May 23rd 2020, 6:00pm

Article

One survivor makes the most of the time in the infusion chair, creating beaded jewelry and helping herself and others to heal.

Teal on Wheels: Riding to Raise Ovarian Cancer Awareness

May 21st 2020, 7:00pm

Podcast

In this episode of the “CURE Talks Cancer” podcast, we spoke with a cervical cancer survivor - who is currently living with ovarian cancer - about a cross-country journey she took last summer on a teal and white Harley Davidson motorcycle to raise ovarian cancer awareness.

What You Need to Know About the FDA's Approval of Lynparza and Avastin for Advanced Ovarian Cancer

May 21st 2020, 1:00am

Article

The Food and Drug Administration recently approved the combination of Lynparza (olaparib) and Avastin (bevacizumab) for patients with advanced ovarian cancer that carries a specific mutation and has responded to previous treatment with platinum-based chemotherapy plus Avastin. Here’s what you need to know.

FDA's Approval of Zejula Offers Patients with High-Grade Ovarian Cancer a Maintenance Therapy Option

May 20th 2020, 1:00am

Article

The Food and Drug Administration’s recent approval of Zejula is different from previous approvals as it is indicated for all patients with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer, according to a gynecologic oncology expert.

Lynparza Maintenance Therapy Improves Survival in Relapsed, BRCA-Positive Ovarian Cancer

May 14th 2020, 1:27am

Article

Treatment with Lynparza in the maintenance setting extended overall survival by more than a year in women with platinum-sensitive relapsed ovarian cancer with BRCA1/2 mutations.

FDA Approves Combination of Lynparza and Avastin as Maintenance Treatment for Advanced Ovarian Cancer

May 8th 2020, 9:30pm

Article

Lynparza and Avastin are now approved for patients with advanced ovarian cancer that carries a specific mutation and has responded to previous treatment with platinum-based chemotherapy plus Avastin.

Ovarian Cancer

May 6th 2020, 6:08am

Article

Understanding ovarian cancer.

FDA Approves Zejula For Maintenance Treatment in Advanced Epithelial Ovarian Cancer

April 29th 2020, 11:20pm

Article

The Food and Drug Administration has approved the use of Zejula as a frontline maintenance treatment for adult patients with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer who responded to chemotherapy.

A Patient with Ovarian Cancer Weathers the COVID-19 Storm at Her Local Health Center

April 16th 2020, 10:14pm

Video

The COVID-19 pandemic has changed how people receive health care services. For Donna Wiegle, director of the Mill Pond Health Center in Maine, and cervical cancer survivor and patient with ovarian cancer, the pandemic hasn’t yet changed how her island’s health center provides residents with routine care.